Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

Rhea-AI Summary

Gritstone bio, Inc. (GRTS) announces participation in key investor and scientific conferences to discuss breakthroughs in vaccine pipeline and leveraging AI for immunotherapies.

EMERYVILLE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor and scientific conferences:

2024 BIO CEO & Investor Conference (Panel)
Panel Title: Reviewing Vaccine Pipeline Breakthroughs and Barriers
Date and Time: Monday, February 26, 2024 at 2:00pm ET
Location: New York, NY

IO360 Summit (Panel)
Panel Title: How to use AI to Leverage Data from Patients in the Clinic to Iterate Next Gen Immunotherapies
Date and Time: Tuesday, February 27, 2024 at 2:30pm ET
Location: New York, NY

44^th Annual TD Cowen Healthcare Conference (Panel)
Panel Title: Novel I-O Corporate Panel
Date and Time: Monday, March 4, 2024 at 10:30am ET
Location: Boston, MA

World Vaccine Congress 2024 (Panel and Presentation)
Panel Title: Exploring the Future Prospects of Cancer Vaccines
Panel Date and Time: Monday, April 3, 2024 at 9:10am ET
Location: Washington, DC

Relevant events will be webcast live and available via https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for 30 days following each event.

About Gritstone bio
Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease. www.gritstonebio.com

Gritstone Contacts
Investors:
George E. MacDougall
Gritstone bio, Inc.
ir@gritstone.com

Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com

 

FAQ

When will Gritstone bio, Inc. participate in the 2024 BIO CEO & Investor Conference?

Gritstone bio, Inc. will participate in the 2024 BIO CEO & Investor Conference on Monday, February 26, 2024, at 2:00pm ET in New York, NY.

What is the focus of the panel at the IO360 Summit conference?

The panel at the IO360 Summit conference will focus on leveraging AI to use data from patients in the clinic for next-gen immunotherapies on Tuesday, February 27, 2024, at 2:30pm ET in New York, NY.

Where will the 44th Annual TD Cowen Healthcare Conference be held?

The 44th Annual TD Cowen Healthcare Conference will be held on Monday, March 4, 2024, at 10:30am ET in Boston, MA.

What will be discussed at the World Vaccine Congress 2024?

The World Vaccine Congress 2024 will explore the future prospects of cancer vaccines on Monday, April 3, 2024, at 9:10am ET in Washington, DC.

Where can the webcasts of the events be accessed?

The webcasts of the events will be available live at https://ir.gritstonebio.com/investors/events and archived replays will be accessible for 30 days following each event.